Proficio Capital Partners LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 181 filers reported holding HAEMONETICS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Proficio Capital Partners LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2019$6,000
+500.0%
46
+360.0%
0.00%
Q1 2019$1,0000.0%10
+25.0%
0.00%
Q3 2018$1,0000.0%8
-33.3%
0.00%
Q2 2018$1,0000.0%120.0%0.00%
Q1 2018$1,0000.0%120.0%0.00%
Q4 2017$1,0000.0%12
-60.0%
0.00%
Q3 2017$1,0000.0%30
-16.7%
0.00%
Q2 2017$1,0000.0%360.0%0.00%
Q1 2017$1,0000.0%36
+5.9%
0.00%
Q4 2016$1,0000.0%34
+3.0%
0.00%
-100.0%
Q3 2016$1,000330.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders